← Leaderboards
Milan N Stojanovic
Columbia University Health Sciences
$13,069,170
Attributed
$19,325,802
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,325,802 · 14
By mechanism
R01$14,176,098 · 5
R21$2,479,066 · 5
RC2$1,814,520 · 1
R35$654,950 · 1
S10$160,232 · 1
F32$40,936 · 1
Top collaborators
- Hao Yan5 shared
- Serge Cremers4 shared
- Qiao Lin4 shared
- Markus Y Mapara4 shared
- Sumit Mohan4 shared
- Ali G Gharavi2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Mehboob A Hussain$12,670,960
- Ruxiao Tian$143,420
Others in their field
Top investigators on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$385,971,304
- Chanza Baytop · Westat, Inc.$271,217,917
- David R. Weir · University Of Michigan At Ann Arbor$186,776,551
- Barton F Haynes · Duke University$162,931,717
Research focus
ComplexAptamerOligonucleotidesBaseProtocols DocumentationMolecularAffinityLaboratoriesSurfaceSensorReceptorDevicesAntibodiesPreventReagentEngineeringProceduresSamplingSmall MoleculeMonitorGenerationsCell SurfaceDesignCells
Grant awards (38)
Towards rapid measurement of antibiotics in critical care setting$657,551
R01 · FY2025 · EB · contact PI
The Logic of Aptamer Isolation$654,950
R35 · FY2025 · GM · contact PI
Towards rapid measurement of antibiotics in critical care setting$656,960
R01 · FY2024 · EB · contact PI
Towards rapid measurement of antibiotics in critical care setting$676,189
R01 · FY2023 · EB · contact PI
Analog-based Approaches to Isolation of Aptamers for Challenging Targets$571,986
R01 · FY2023 · GM · contact PI
Analog-based Approaches to Isolation of Aptamers for Challenging Targets$61,000
R01 · FY2023 · GM · contact PI
Towards rapid measurement of antibiotics in critical care setting$697,163
R01 · FY2022 · EB · contact PI
Analog-based Approaches to Isolation of Aptamers for Challenging Targets$571,986
R01 · FY2022 · GM · contact PI
Graft Engineering of Allogeneic Hematopoietic Stem Cell Products with Molecular Cascades$646,892
R01 · FY2021 · EB · contact PI
Analog-based Approaches to Isolation of Aptamers for Challenging Targets$571,986
R01 · FY2021 · GM · contact PI
Analog-based Approaches to Isolation of Aptamers for Challenging Targets$45,245
R01 · FY2021 · GM · contact PI
Graft Engineering of Allogeneic Hematopoietic Stem Cell Products with Molecular Cascades$665,709
R01 · FY2020 · EB · contact PI
Analog-based Approaches to Isolation of Aptamers for Challenging Targets$470,667
R01 · FY2020 · GM · contact PI
Graft Engineering of Allogeneic Hematopoietic Stem Cell Products with Molecular Cascades$656,925
R01 · FY2019 · EB · contact PI
Graft Engineering of Allogeneic Hematopoietic Stem Cell Products with Molecular Cascades$658,221
R01 · FY2018 · EB · contact PI
Aptamer-Based Arrays for Detection of Pathogenic IgA1 O-Glycoforms in IgA Nephropathy$200,347
R21 · FY2017 · DK · contact PI
Theranostic Nano-objects: Basic Principles and Initial Applications$1,036,826
R01 · FY2016 · GM · contact PI
Automated Microfluidic Selection of Aptamers against Carbohydrates$306,206
R21 · FY2016 · CA · contact PI
Aptamer-Based Arrays for Detection of Pathogenic IgA1 O-Glycoforms in IgA Nephropathy$251,130
R21 · FY2016 · DK · contact PI
Theranostic Nano-objects: Basic Principles and Initial Applications$1,042,320
R01 · FY2015 · GM · contact PI
Automated Microfluidic Selection of Aptamers against Carbohydrates$306,206
R21 · FY2015 · CA · contact PI
Theranostic Nano-objects: Basic Principles and Initial Applications$1,065,348
R01 · FY2014 · GM · contact PI
UPLC Liquid Chromatograph Mass Spectrometer$160,232
S10 · FY2014 · OD · contact PI
Theranostic Nano-objects: Basic Principles and Initial Applications$1,067,098
R01 · FY2013 · GM · contact PI
Isolation of narrow subpopulations of cells using molecular computing cascades$195,908
R21 · FY2013 · EB · contact PI
Theranostic Nano-objects: Basic Principles and Initial Applications$1,190,653
R01 · FY2012 · GM · contact PI
Isolation of narrow subpopulations of cells using molecular computing cascades$266,625
R21 · FY2012 · EB · contact PI
Aptameric Modulation of Relaxivity in MRI Contrast Agents$201,250
R21 · FY2012 · EB · contact PI
Aptameric Modulation of Relaxivity in MRI Contrast Agents$241,500
R21 · FY2011 · EB · contact PI
Theranostic Molecular Automata for Specific Cell Elimination$912,300
RC2 · FY2010 · CA · contact PI
Theranostic Molecular Automata for Specific Cell Elimination$902,220
RC2 · FY2009 · CA · contact PI
Therapeutic Self-Assembly of Recognition Elements on Cell Surfaces$164,920
R21 · FY2009 · CA · contact PI
Therapeutic Self-Assembly of Recognition Elements on Cell Surfaces$164,920
R21 · FY2008 · CA · contact PI
Therapeutic Self-Assembly of Recognition Elements on Cell Surfaces$180,054
R21 · FY2007 · CA · contact PI
DNA-based Arrays of Cross-reactive Molecular Sensors$367,875
R01 · FY2004 · EB
DNA-based Arrays of Cross-reactive Molecular Sensors$408,750
R01 · FY2003 · EB
DNA-based Arrays of Cross-reactive Molecular Sensors$388,748
R01 · FY2002 · EB
IMPROVE HAPTEN DESIGN FOR ANTICOCAINE CATALYTIC ANTIBODY$40,936
F32 · FY2000 · DA